Abstract:Obesity-associated metabolic abnormalities comprise a cluster of conditions including dyslipidemia, insulin resistance, diabetes and cardiovascular diseases that has affected more than 650 million people all over the globe. Obesity results from the accumulation of white adipose tissues mainly due to the chronic imbalance of energy intake and energy expenditure. A variety of approaches to treat or prevent obesity, including lifestyle interventions, surgical weight loss procedures and pharmacological approaches to reduce energy intake and increase energy expenditure have failed to substantially decrease the prevalence of obesity. Brown adipose tissue (BAT), the primary source of thermogenesis in infants and small mammals may represent a promising therapeutic target to treat obesity by promoting energy expenditure through non-shivering thermogenesis mediated by mitochondrial uncoupling protein 1 (UCP1). Since the confirmation of functional BAT in adult humans by several groups, approximately a decade ago, and its association with a favorable metabolic phenotype, intense interest on the significance of BAT in adult human physiology and metabolic health has emerged within the scientific community to explore its therapeutic potential for the treatment of obesity and metabolic diseases. A substantially decreased BAT activity in individuals with obesity indicates a role for BAT in the setting of human obesity. On the other hand, BAT mass and its prevalence correlate with lower body mass index (BMI), decreased age and lower glucose levels, leading to a lower incidence of cardio-metabolic diseases. The increased cold exposure in adult humans with undetectable BAT was associated with decreased body fat mass and increased insulin sensitivity. A deeper understanding of the role of BAT in human metabolic health and its interrelationship with body fat distribution and deciphering proper strategies to increase energy expenditure, by either increasing functional BAT mass or inducing white adipose browning, holds the promise for possible therapeutic avenues for the treatment of obesity and associated metabolic disorders.

Brown adipose tissue fights the battle against leukaemia

Identification and characterization of distinct brown adipocyte subtypes in C57BL/6J mice

Brown and beige fat: development, function and therapeutic potential

Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus

Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia

Effective Prevention and Treatment of Acute Leukemias in Mice by Activation of Thermogenic Adipose Tissues

Effective Prevention and Treatment of Acute Leukemias in Mice by Activation of Thermogenic Adipose Tissues (Adv. Sci. 38/2024)

Identification and Characterization of Distinct Murine Brown Adipocyte Lineages

Brown-fat-mediated tumour suppression by cold-altered global metabolism

Human beige adipocytes for drug discovery and cell therapy in metabolic diseases

Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues

Brown adipose tissue is associated with cardiometabolic health

Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis

Branching out beyond canonical brown adipocyte function

Brown fat thermogenesis and branched-chain amino acids in metabolic disease

Immunomodulatory leptin receptor+ sympathetic perineurial barrier cells protect against obesity by facilitating brown adipose tissue thermogenesis

Brown Fat and Nutrition: Implications for Nutritional Interventions

Molecular pathways regulating the formation of brown-like adipocytes in white adipose tissue

An update on brown adipose tissue and obesity intervention: Function, regulation and therapeutic implications

Brown adipose tissue: endocrine determinants of function and therapeutic manipulation as a novel treatment strategy for obesity

Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.